UnknownNot Applicable

Therapy Management in Patients Treated With Anakinra Due to Recurrent Pericarditis

Italy20 participantsStarted 2018-01-01

Plain-language summary

To determine the utility of serial cardiac magnetic resonance (CMR) imaging for guidance of therapy management in patients treated with anakinra due to recurrent pericarditis (RP), compared with c-reactive protein (CRP) assay alone.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients treated with anakinra 100 mg/die if ≥ 18 years old, and * Pediatric patients treated with anakinra 2 mg/kg/die if \< 18 years old * Pediatric and adult patients treated with anakinra due to corticosteroid-dependent or not responsive to colchicine or non-steroidal anti-inflammatory drugs (NSAIDs) recurrent pericarditis Exclusion Criteria: * Ongoing infection (proved within serology) * Refuse to participate in the trial

What they're measuring

Recurrences of pericarditis

Timeframe: 6 month

Trial details

NCT IDNCT06071156

SponsorAzienda Ospedaliero, Universitaria Ospedali Riuniti

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2022-05-05

Contact for this trial

Francesco Bianco, M.D., Ph.D.

+390715965517 francesco.bianco@ospedaliriuniti.marche.it

View on ClinicalTrials.gov More Recurrent Pericarditis trials